Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.

Hernström V, Josefsson V, Sartor H, Schmidt D, Larsson AM, Hofvind S, Andersson I, Rosso A, Hagberg O, Lång K

Open source

DOI
10.1016/s2589-7500(24)00267-x
Published
2025 Mar
Container
The Lancet. Digital health
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2589-7500-24-00267-x,
  title = {Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.},
  author = {Hernström V and Josefsson V and Sartor H and Schmidt D and Larsson AM and Hofvind S and Andersson I and Rosso A and Hagberg O and Lång K},
  year = {2025},
  journal = {The Lancet. Digital health},
  doi = {10.1016/s2589-7500(24)00267-x},
  url = {https://doi.org/10.1016/s2589-7500(24)00267-x}
}

RIS

TY  - JOUR
TI  - Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.
AU  - Hernström V
AU  - Josefsson V
AU  - Sartor H
AU  - Schmidt D
AU  - Larsson AM
AU  - Hofvind S
AU  - Andersson I
AU  - Rosso A
AU  - Hagberg O
AU  - Lång K
PY  - 2025
JO  - The Lancet. Digital health
DO  - 10.1016/s2589-7500(24)00267-x
UR  - https://doi.org/10.1016/s2589-7500(24)00267-x
ER  - 

APA

V, H., V, J., H, S., D, S., AM, L., S, H., I, A., A, R., O, H., & K, L. (2025). Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study.. The Lancet. Digital health. https://doi.org/10.1016/s2589-7500(24)00267-x

Source records